XML 45 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value of Assets and Liabilities (Tables)
9 Months Ended
Sep. 30, 2015
Fair Value Disclosures [Abstract]  
Summary of assets and liabilities measured at fair value on a recurring and non-recurring basis
The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring and non-recurring basis as of December 31, 2014.
($ in millions)
Quoted prices
in active
markets for
identical assets
(Level 1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
Counterparty
and cash
collateral
netting
 
Balance as of December 31, 2014
Assets
 

 
 

 
 

 
 

 
 

Fixed income securities:
 

 
 

 
 

 
 

 
 

U.S. government and agencies
$
147

 
$
623

 
$

 
 

 
$
770

Municipal

 
3,556

 
106

 
 

 
3,662

Corporate

 
20,193

 
792

 
 

 
20,985

Foreign government

 
735

 

 
 

 
735

ABS

 
636

 
129

 
 

 
765

RMBS

 
605

 

 
 

 
605

CMBS

 
578

 
1

 
 

 
579

Redeemable preferred stock

 
16

 

 
 

 
16

Total fixed income securities
147

 
26,942

 
1,028

 
 

 
28,117

Equity securities
927

 
6

 
37

 
 

 
970

Short-term investments
90

 
767

 

 
 

 
857

Other investments: Free-standing derivatives

 
90

 
2

 
$
(2
)
 
90

Separate account assets
4,396

 

 

 
 
 
4,396

Other assets
1

 

 
1

 
 
 
2

Total recurring basis assets
5,561

 
27,805

 
1,068

 
(2
)
 
34,432

Non-recurring basis (1)

 

 
9

 


 
9

Total assets at fair value
$
5,561

 
$
27,805

 
$
1,077

 
$
(2
)
 
$
34,441

% of total assets at fair value
16.2
%
 
80.7
%
 
3.1
%
 
 %
 
100.0
%
 
 
 
 
 
 
 
 
 
 
Liabilities
 

 
 

 
 

 
 

 
 

Contractholder funds: Derivatives embedded in life and annuity contracts
$

 
$

 
$
(323
)
 
 

 
$
(323
)
Other liabilities: Free-standing derivatives

 
(24
)
 
(9
)
 
$
2

 
(31
)
Total liabilities at fair value
$

 
$
(24
)
 
$
(332
)
 
$
2

 
$
(354
)
% of total liabilities at fair value
%
 
6.8
%
 
93.8
%
 
(0.6
)%
 
100.0
%
 
____________
(1) 
Includes $6 million of mortgage loans and $3 million of limited partnership interests written-down to fair value in connection with recognizing other-than-temporary impairments.
The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring and non-recurring basis as of September 30, 2015.
($ in millions)
Quoted prices
in active
markets for
identical assets
(Level 1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
Counterparty
and cash
collateral
netting
 
Balance as of September 30, 2015
Assets
 

 
 

 
 

 
 

 
 

Fixed income securities:
 

 
 

 
 

 
 

 
 

U.S. government and agencies
$
136

 
$
440

 
$

 
 

 
$
576

Municipal

 
2,437

 
89

 
 

 
2,526

Corporate

 
18,368

 
535

 
 

 
18,903

Foreign government

 
430

 

 
 

 
430

ABS

 
1,590

 
131

 
 

 
1,721

RMBS

 
489

 

 
 

 
489

CMBS

 
512

 

 
 

 
512

Redeemable preferred stock

 
16

 

 
 

 
16

Total fixed income securities
136

 
24,282

 
755

 
 

 
25,173

Equity securities
1,300

 
6

 
64

 
 

 
1,370

Short-term investments
51

 
886

 

 
 

 
937

Other investments: Free-standing derivatives

 
35

 
1

 
$
(11
)
 
25

Separate account assets
3,677

 

 

 
 
 
3,677

Other assets

 

 
1

 
 
 
1

Total recurring basis assets
5,164

 
25,209

 
821

 
(11
)
 
31,183

Non-recurring basis (1)

 

 
7

 

 
7

Total assets at fair value
$
5,164

 
$
25,209

 
$
828

 
$
(11
)
 
$
31,190

% of total assets at fair value
16.5
%
 
80.8
%
 
2.7
%
 
 %
 
100
%
 
 
 
 
 
 
 
 
 
 
Liabilities
 

 
 

 
 

 
 

 
 

Contractholder funds: Derivatives embedded in life and annuity contracts
$

 
$

 
$
(295
)
 
 

 
$
(295
)
Other liabilities: Free-standing derivatives
(2
)
 
(1
)
 
(9
)
 
$
(1
)
 
(13
)
Total liabilities at fair value
$
(2
)
 
$
(1
)
 
$
(304
)
 
$
(1
)
 
$
(308
)
% of total liabilities at fair value
0.7
%
 
0.3
%
 
98.7
%
 
0.3
 %
 
100
%
 ____________
(1) 
Includes $7 million of other investments written-down to fair value in connection with recognizing other-than-temporary impairments.
Summary of quantitative information about the significant unobservable inputs used in Level 3 fair value measurements
The following table summarizes quantitative information about the significant unobservable inputs used in Level 3 fair value measurements.
($ in millions)
Fair value
 
Valuation
technique
 
Unobservable
input
 
Range
 
Weighted
average
September 30, 2015
 

 
 
 
 
 
 
 
 

Derivatives embedded in life and annuity contracts – Equity-indexed and forward starting options
$
(242
)
 
Stochastic cash flow model
 
Projected option cost
 
1.0 - 2.2%
 
1.76
%
December 31, 2014
 

 
 
 
 
 
 
 
 

Derivatives embedded in life and annuity contracts – Equity-indexed and forward starting options
$
(278
)
 
Stochastic cash flow model
 
Projected option cost
 
1.0 - 2.0%
 
1.76
%
Schedule of rollforward of Level 3 assets and liabilities held at fair value on a recurring basis
The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the three months ended September 30, 2015.
($ in millions)
 
 
Total gains (losses)
included in:
 
 
 
 
 
 
 
Balance as of June 30, 2015
 
Net
income (1)
 
OCI
 
Transfers
into
Level 3
 
Transfers
out of
Level 3
 
 
Assets
 

 
 

 
 

 
 

 
 

 
 
Fixed income securities:
 

 
 

 
 

 
 

 
 

 
 
Municipal
$
101

 
$
2

 
$

 
$

 
$

 
 
Corporate
569

 
10

 
(9
)
 

 
(23
)
 
 
ABS
105

 

 
(1
)
 
15

 

 
 
Total fixed income securities
775

 
12

 
(10
)
 
15

 
(23
)
 
 
Equity securities
46

 

 
(1
)
 

 

 
 
Free-standing derivatives, net
(7
)
 
(1
)
 

 

 

 
 
Other assets
1

 

 

 

 

 
 
Total recurring Level 3 assets
$
815

 
$
11

 
$
(11
)
 
$
15

 
$
(23
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 

 
 

 
 

 
 

 
 

 
 
Contractholder funds: Derivatives embedded in life and annuity contracts
$
(315
)
 
$
19

 
$

 
$

 
$

 
 
Total recurring Level 3 liabilities
$
(315
)
 
$
19

 
$

 
$

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Purchases
 
Sales
 
Issues
 
Settlements
 
Balance as of September 30, 2015
 
 
Assets
 

 
 

 
 
 
 

 
 

 
 
Fixed income securities:
 

 
 

 
 
 
 

 
 

 
 
Municipal
$

 
$
(14
)
 
$

 
$

 
$
89

 
 
Corporate
1

 
(11
)
 

 
(2
)
 
535

 
 
ABS
27

 

 

 
(15
)
 
131

 
 
Total fixed income securities
28

 
(25
)
 

 
(17
)
 
755

 
 
Equity securities
19

 

 

 

 
64

 
 
Free-standing derivatives, net

 

 

 

 
(8
)
 
(2) 
Other assets

 

 

 

 
1

 
 
Total recurring Level 3 assets
$
47

 
$
(25
)
 
$

 
$
(17
)
 
$
812

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 

 
 

 
 
 
 

 
 

 
 
Contractholder funds: Derivatives embedded in life and annuity contracts
$

 
$

 
$

 
$
1

 
$
(295
)
 
 
Total recurring Level 3 liabilities
$

 
$

 
$

 
$
1

 
$
(295
)
 
 
 ____________
(1) 
The effect to net income totals $30 million and is reported in the Condensed Consolidated Statements of Operations and Comprehensive Income as follows: $8 million in realized capital gains and losses, $3 million in net investment income, $27 million in interest credited to contractholder funds and $(8) million in contract benefits.
(2) 
Comprises $1 million of assets and $9 million of liabilities.

The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the three months ended September 30, 2014.
($ in millions)
 
 
Total gains (losses) included in:
 
 
 
 
 
 
 
Balance as of June 30, 2014
 
Net
income (1)
 
OCI
 
Transfers
into
Level 3
 
Transfers
out of
Level 3
 
 
Assets
 

 
 

 
 

 
 

 
 

 
 
Fixed income securities:
 

 
 

 
 

 
 

 
 

 
 
Municipal
$
102

 
$

 
$

 
$

 
$

 
 
Corporate
883

 
3

 
(13
)
 
18

 

 
 
ABS
105

 

 
1

 

 

 
 
CMBS
5

 

 

 

 

 
 
Total fixed income securities
1,095

 
3

 
(12
)
 
18

 

 
 
Equity securities
7

 

 

 

 

 
 
Free-standing derivatives, net
(5
)
 

 

 

 

 
 
Other assets
1

 

 

 

 

 
 
Total recurring Level 3 assets
$
1,098

 
$
3

 
$
(12
)
 
$
18

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 

 
 

 
 

 
 

 
 

 
 
Contractholder funds: Derivatives embedded in life and annuity contracts
$
(331
)
 
$
9

 
$

 
$

 
$

 
 
Total recurring Level 3 liabilities
$
(331
)
 
$
9

 
$

 
$

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Purchases
 
Sales
 
Issues
 
Settlements
 
Balance as of September 30, 2014
 
 
Assets
 

 
 

 
 

 
 

 
 

 
 
Fixed income securities:
 

 
 

 
 

 
 

 
 

 
 
Municipal
$

 
$
(1
)
 
$

 
$

 
$
101

 
 
Corporate
4

 
(3
)
 

 
(53
)
 
839

 
 
ABS
10

 

 

 
(2
)
 
114

 
 
CMBS

 

 

 

 
5

 
 
Total fixed income securities
14

 
(4
)
 

 
(55
)
 
1,059

 
 
Equity securities
30

 

 

 

 
37

 
 
Free-standing derivatives, net

 

 

 
(1
)
 
(6
)
 
(2) 
Other assets

 

 

 

 
1

 
 
Total recurring Level 3 assets
$
44

 
$
(4
)
 
$

 
$
(56
)
 
$
1,091

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 

 
 

 
 

 
 

 
 

 
 
Contractholder funds: Derivatives embedded in life and annuity contracts
$

 
$

 
$

 
$
1

 
$
(321
)
 
 
Total recurring Level 3 liabilities
$

 
$

 
$

 
$
1

 
$
(321
)
 
 
__________
(1) 
The effect to net income totals $12 million and is reported in the Condensed Consolidated Statements of Operations and Comprehensive Income as follows: $3 million in net investment income, $5 million in interest credited to contractholder funds and $4 million in contract benefits.
(2) 
Comprises $3 million of assets and $9 million of liabilities.
The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the nine months ended September 30, 2014.
($ in millions)
 
 
Total gains (losses)included in:
 
 
 
 
 
 
 
Balance as of December 31, 2013
 
Net
income (1)
 
OCI
 
Transfers
into
Level 3
 
Transfers
out of
Level 3
 
 
Assets
 

 
 

 
 

 
 

 
 

 
 
Fixed income securities:
 

 
 

 
 

 
 

 
 

 
 
Municipal
$
119

 
$
(1
)
 
$
3

 
$

 
$
(17
)
 
 
Corporate
1,008

 
14

 
(4
)
 
18

 
(26
)
 
 
ABS
112

 

 
2

 

 
(12
)
 
 
CMBS
1

 

 

 

 

 
 
Redeemable preferred stock
1

 

 

 

 

 
 
Total fixed income securities
1,241

 
13

 
1

 
18

 
(55
)
 
 
Equity securities
6

 

 

 

 

 
 
Free-standing derivatives, net
(5
)
 
1

 

 

 

 
 
Other assets

 
1

 

 

 

 
 
Assets held for sale
362

 
(1
)
 
2

 
4

 
(2
)
 
 
Total recurring Level 3 assets
$
1,604

 
$
14

 
$
3

 
$
22

 
$
(57
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 

 
 

 
 

 
 

 
 

 
 
Contractholder funds: Derivatives embedded in life and annuity contracts
$
(307
)
 
$
(5
)
 
$

 
$

 
$

 
 
Liabilities held for sale
(246
)
 
17

 

 

 

 
 
Total recurring Level 3 liabilities
$
(553
)
 
$
12

 
$

 
$

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sold in LBL disposition (3)
 
Purchases/Issues  (4)
 
Sales
 
Settlements
 
Balance as of September 30, 2014
 
 
Assets
 

 
 

 
 

 
 

 
 

 
 
Fixed income securities:
 

 
 

 
 

 
 

 
 

 
 
Municipal
$

 
$

 
$
(3
)
 
$

 
$
101

 
 
Corporate

 
16

 
(92
)
 
(95
)
 
839

 
 
ABS

 
21

 

 
(9
)
 
114

 
 
CMBS
4

 

 

 

 
5

 
 
Redeemable preferred stock

 

 
(1
)
 

 

 
 
Total fixed income securities
4

 
37

 
(96
)
 
(104
)
 
1,059

 
 
Equity securities

 
31

 

 

 
37

 
 
Free-standing derivatives, net

 
2

 

 
(4
)
 
(6
)
 
(2) 
Other assets

 

 

 

 
1

 
 
Assets held for sale
(351
)
 

 
(8
)
 
(6
)
 

 
 
Total recurring Level 3 assets
$
(347
)
 
$
70

 
$
(104
)
 
$
(114
)
 
$
1,091

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 

 
 

 
 

 
 

 
 

 
 
Contractholder funds: Derivatives embedded in life and annuity contracts
$

 
$
(13
)
 
$

 
$
4

 
$
(321
)
 
 
Liabilities held for sale
230

 
(4
)
 

 
3

 

 
 
Total recurring Level 3 liabilities
$
230

 
$
(17
)
 
$

 
$
7

 
$
(321
)
 
 
__________
(1) 
The effect to net income totals $26 million and is reported in the Condensed Consolidated Statements of Operations and Comprehensive Income as follows: $8 million in realized capital gains and losses, $9 million in net investment income, $5 million in interest credited to contractholder funds, $8 million in contract benefits and $(4) million in loss on disposition of operations.
(2) 
Comprises $3 million of assets and $9 million of liabilities.
(3) 
Includes transfers from held for sale that took place in first quarter 2014 of $4 million for CMBS and $(4) million for Assets held for sale.
(4) 
Represents purchases for assets and issues for liabilities.

Schedule of change in unrealized gains and losses included in net income for Level 3 assets and liabilities held
The following table provides the change in unrealized gains and losses included in net income for Level 3 assets and liabilities held as of September 30.
($ in millions)
Three months ended September 30,
 
Nine months ended September 30,
 
2015
 
2014
 
2015
 
2014
Assets
 

 
 

 
 

 
 

Fixed income securities:
 

 
 

 
 

 
 

Municipal
$

 
$

 
$

 
$
(1
)
Corporate
3

 
3

 
8

 
8

ABS

 

 
1

 

CMBS

 

 

 
(1
)
Total fixed income securities
3

 
3

 
9

 
6

Equity securities
(1
)
 

 

 

Free-standing derivatives, net
(1
)
 

 

 
6

Other assets

 

 

 
1

Assets held for sale

 

 

 
(1
)
Total recurring Level 3 assets
$
1

 
$
3

 
$
9

 
$
12

 
 
 
 
 
 
 
 
Liabilities
 

 
 

 
 

 
 

Contractholder funds: Derivatives embedded in life and annuity contracts
$
19

 
$
9

 
$
24

 
$
(5
)
Liabilities held for sale

 

 

 
17

Total recurring Level 3 liabilities
$
19

 
$
9

 
$
24

 
$
12

Schedule of carrying values and fair value estimates of financial instruments not carried at fair value
Financial assets
($ in millions)
September 30, 2015
 
December 31, 2014
 
Carrying
value
 
Fair
value
 
Carrying
value
 
Fair
value
Mortgage loans
$
3,827

 
$
4,020

 
$
3,686

 
$
3,922

Cost method limited partnerships
526

 
692

 
508

 
686

Bank loans
510

 
507

 
431

 
427

Agent loans
416

 
406

 
368

 
361

Notes due from related party
275

 
275

 
275

 
275

Financial liabilities
($ in millions)
September 30, 2015
 
December 31, 2014
 
Carrying
value
 
Fair
value
 
Carrying
value
 
Fair
value
Contractholder funds on investment contracts
$
12,682

 
$
13,189

 
$
13,708

 
$
14,364

Notes due to related parties
275

 
275

 
275

 
275

Liability for collateral
503

 
503

 
510

 
510